SEC Form 13F

NAN FUNG TRINITY (HK) LTD 13F Holdings

Inspect NAN FUNG TRINITY (HK) LTD's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-07-25T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-07-25
Reported value
$1,012,751,794
Positions
55

Disclosed positions

ADVANCED MICRO DEVICES INCAMDCOM$67,792,197116,700SHNone
AMCOR PLCAMCRCOM NEW$52,001,6201,199,576SHNone
PPG INDS INCPPGCOM$48,192,641397,334SHNone
GE HEALTHCARE TECHNOLOGIES IGEHCCOMMON STOCK$40,881,587638,675SHNone
NVIDIA CORPORATIONNVDACOM$36,064,222180,240SHNone
HOME DEPOT INCHDCOM$35,239,43399,919SHNone
KT CORPKTSPONSORED ADR$33,788,2751,955,340SHNone
ISHARES TREIDOMSCI INDONIA ETF$33,747,9092,983,900SHNone
ISHARES TRMBBMBS ETF$33,006,384349,200SHNone
OWENS CORNING NEWOCCOM$29,618,063186,324SHNone
UNITEDHEALTH GROUP INCUNHCOM$28,402,07668,335SHNone
AIR PRODUCTS AND CHEMICALS IAPDCOM$28,344,64296,680SHNone
ISHARES TRIJHCORE S&P MCP ETF$27,682,490359,000SHNone
AMERICA MOVIL SAB DE CVAMXSPON ADS RP CL B$27,432,4451,055,500SHNone
MIRUM PHARMACEUTICALS INCMIRMCOM$27,239,731232,679SHNone
DANAHER CORP DELDHRCOM$24,095,720126,500SHNone
TREVI THERAPEUTICS INCTRVICOM$22,634,0131,213,620SHNone
META PLATFORMS INCMETACL A$21,044,51437,360SHNone
PROTAGONIST THERAPEUTICS INCPTGXCOM$19,694,929160,670SHNone
ABIVAX SAABVXSPONSORED ADS$18,933,981142,083SHNone
SPDR SERIES TRUSTXHBST STR SP HOME$17,916,422155,040SHNone
JD.COM INCJDSPON ADS CL A$16,554,356649,700SHNone
BRIDGEBIO PHARMA INCBBIOCOM$16,327,133219,215SHNone
MP MATERIALS CORPMPCOM CL A$15,853,631283,050SHNone
PDD HOLDINGS INCPDDSPONSORED ADS$15,843,280207,699SHNone
SCHOLAR ROCK HLDG CORPSRRKCOM$15,702,225285,495SHNone
WARNER BROS DISCOVERY INCWBDCOM SER A$15,349,335575,744SHNone
IMMUNOME INCIMNMCOM$15,141,378714,553SHNone
XENON PHARMACEUTICALS INCXENECOM$14,955,095247,765SHNone
IREN LIMITEDIRENORDINARY SHARES$13,489,115294,973SHNone
KURA ONCOLOGY INCKURACOM$12,888,4341,174,880SHNone
BICARA THERAPEUTICS INCBCAXCOM$12,703,906427,885SHNone
ALEXANDRIA REAL ESTATE EQ INARECOM$12,630,146238,981SHNone
HONEYWELL INTL INCHONCOM$12,348,08555,150SHNone
HONEYWELL AEROSPACE INCHONACOM$12,192,56255,150SHNone
VOR BIOPHARMA INCVORCOM NEW$11,902,986646,550SHNone
FLEX LTDFLEXORD$11,717,66172,300SHNone
CRH PLCCRHORD$11,416,900106,700SHNone
SAVARA INCSVRACOM$11,348,8761,842,350SHNone
CELCUITY INCCELCCOM$10,856,941103,775SHNone
BXP INCBXPCOM$8,084,780121,924SHNone
KILROY REALTY CORPKRCCOM$7,898,676210,800SHNone
VAXCYTE INCPCVXCOM$7,145,921122,930SHNone
SL GREEN RLTY CORPSLGCOM$6,859,887132,507SHNone
ZAI LAB LTDZLABADR$6,582,854346,466SHNone
ABEONA THERAPEUTICS INCABEOCOM NEW$5,912,839956,770SHNone
VORNADO RLTY TRVNOSH BEN INT$5,651,340143,800SHNone
UNIQURE NVQURESHS$5,319,654115,494SHNone
CLIMB BIO INCCLYMCOM$4,702,928360,654SHNone
BIOCRYST PHARMACEUTICALS INCBCRXCOM$4,500,000450,000SHNone

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.